Plain-language definitions grounded in the clinical and regulatory literature.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Pharmacogenetics
What it isThe liver enzyme that breaks down caffeine. Genetic variation in CYP1A2 explains why some people can drink coffee at 8 PM and sleep fine, while others cannot.
Why it mattersCYP1A2 polymorphisms divide people into fast and slow caffeine metabolizers. Slow metabolizers experience caffeine’s effects longer, increasing risk of caffeine-related insomnia and arrhythmia.
Think of it like thisTwo people drink the same espresso. One processes the caffeine in 3 hours; the other takes 8. They have the same drink but live in different pharmacokinetic worlds.
A cytochrome P450 enzyme encoded by the CYP1A2 gene on chromosome 15q24.1, responsible for ~95 percent of caffeine demethylation. Common polymorphisms (notably -163C>A, rs762551) classify individuals as rapid (AA) or slow (AC/CC) metabolizers.
MechanismCYP1A2 catalyzes the N3-demethylation of caffeine to paraxanthine, the rate-limiting step in caffeine elimination. The -163C>A polymorphism affects enzyme inducibility rather than baseline activity. Smoking induces CYP1A2 activity. Slow metabolizers show prolonged caffeine half-life (up to 8-9 hours vs 3-5 hours in rapid metabolizers).
Scientific ConsensusCYP1A2 is the primary enzyme for caffeine metabolism. Genetic polymorphism produces clinically meaningful variation in caffeine half-life and effects. Slow metabolizers have higher risk for caffeine-related cardiovascular events at the same caffeine intake.
Active DebateThe clinical utility of CYP1A2 genotyping for personalizing caffeine recommendations. The relative contribution of CYP1A2 polymorphism vs adenosine receptor (ADORA2A) polymorphism to individual caffeine response. Interactions with other lifestyle factors.
Emerging ResearchDirect-to-consumer genetic testing including CYP1A2 status. Pharmacogenetic-guided caffeine recommendations for shift workers and operational personnel. Personalized caffeine timing based on individual half-life estimates.
Key ResearchCornelis et al. established the CYP1A2 polymorphism’s effect on cardiovascular risk associated with coffee intake. Sachse et al. characterized the -163C>A polymorphism’s effects on enzyme inducibility. Yang et al. reviewed caffeine pharmacogenetics.
— CYP1A2 genotype and clinical effects of caffeine
— Functional characterization of -163C>A polymorphism
Sleep disorders, PTSD, and the invisible wounds of service can feel isolating. If you or someone you know is in crisis or experiencing thoughts of self-harm, help is available right now. The Veterans Crisis Line provides free, confidential support 24 hours a day, 7 days a week to veterans, service members, and their families.
If you are in crisis or experiencing thoughts of self-harm, call the Veterans Crisis Line at